1-11 of 11
Nikhil Munshi, M.D
Close
Sort by
Journal Articles

An Open-Label Phase I Study of the Safety and Efficacy of RAD001 in Combination with Lenalidomide in the Treatment of Patients with Relapsed and Relapsed/Refractory Multiple Myeloma.

Noopur Raje, MD., Paul Richardson, M.D., Parameswaran N Hari, MD, Anuj Mahindra, Sarah Kaster, BS, Christine Connolly, Linda Rivera, Gaurav Chetri, Sarah Dean, Paulette Jacobs, Ayman Saad, MD, Jacob Laubach, Irene M. Ghobrial, M.D., Robert L Schlossman, M.D., Ph.D., Jennifer Adams, Wendy Makrides, Edie Weller, PhD, Nikhil Munshi, M.D., Kenneth C. Anderson, MD
Journal: Blood
Blood (2009) 114 (22): 3856.
https://doi.org/10.1182/blood.V114.22.3856.3856
Published: 2009
Journal Articles

Molecular Profiling of Extramedullary and Medullary Plasmacytomas

Gabriela Motyckova, M.D., Ph.D., Aliyah Rahemtullah, M.D., Nileshwari Vaghela, M.S., Sonia Vallet, M.D., Adam Ackerman, Siddhartha Mukherjee, M.D., Ph.D., Samantha Pozzi, M.D., Loredana Santo, Ph.D., Diana Cirstea, M.D., Christiana Toomey, Ephraim P. Hochberg, M.D., Paola Dal Cin, Ph.D., Scott Rodig, M.D., Ph.D., Teru Hideshima, M.D., Ph.D., Kenneth C Anderson, M.D., Nikhil Munshi, M.D., Noopur Raje, M.D.
Journal: Blood
Blood (2008) 112 (11): 5111.
https://doi.org/10.1182/blood.V112.11.5111.5111
Published: 2008
Journal Articles

Combination of Proteasome Inhibitors Bortezomib and NPI-0052 Trigger In Vivo Synergistic Cytotoxicity in Multiple Myeloma.

Dharminder Chauhan, PhD, Ajita Singh, Ph.D, Mohan Brahmandam, M.S, Klaus Podar, Ph.D, Teru Hideshima, M.D., Robert Schlossman, M.D., Paul Richardson, M.D., Nikhil Munshi, M.D., Michael Palladino, Ph.D, Kenneth C. Anderson, M.D.
Journal: Blood
Blood (2007) 110 (11): 2524.
https://doi.org/10.1182/blood.V110.11.2524.2524
Published: 2007
Journal Articles

Acquisition of New In Vivo Genomic Change over Time in Multiple Myeloma.

Yu-Tzu Tai, PhD, Leutz Buon, M.S., Benjamin King, B.S., Cheng Li Cheng Li, Ph.D., Peter Burger Peter Burger, B.S., Xian-Feng Li, M.S., Weihua Song, M.D., Robert Schlossman, M.D., Paul Richardson, M.D., Kenneth C. Anderson, M.D., Nikhil Munshi, M.D.
Journal: Blood
Blood (2007) 110 (11): 2481.
https://doi.org/10.1182/blood.V110.11.2481.2481
Published: 2007
Journal Articles

Plasmacytoid Dendritic Cells Induce Growth and Survival of Multiple Myeloma Cells: Therapeutic Application.

Dharminder Chauhan, PhD, Mohan Brahmandam, M.S., Ajita Singh, Ph.D, Giada Bianchi, M.D., Klaus Podar, M.D., Ruben Carrasco, Ph.D, Paul Richardson, M.D., Nikhil Munshi, M.D., Kenneth C. Anderson, M.D.
Journal: Blood
Blood (2007) 110 (11): 3507.
https://doi.org/10.1182/blood.V110.11.3507.3507
Published: 2007
Journal Articles

Bcl-2, Mcl-1 and p53 Expression Confer Sensitivity to Bcl-2 Inhibitor ABT-737 in Multiple Myeloma.

Dharminder Chauhan, PhD, Mohan Brahmandam, M.S, Teru Hideshima, Ph.D, Klaus Podar, Ph.D, Nikhil Munshi, M.D, Noopur Raje, M.D, Kenneth C. Anderson, M.D
Journal: Blood
Blood (2006) 108 (11): 3474.
https://doi.org/10.1182/blood.V108.11.3474.3474
Published: 2006
Journal Articles

p38MAPK Inhibitor LSN2322600 Modulates the Bone Marrow Microenvironment and Inhibits Osteoclastogenesis in Multiple Myeloma.

Kenji Ishitsuka, MD, PhD, Teru Hideshima, M.D., Ph.D., Paola Neri, M.D., Ph.D., Sonia Vallet, M.D., Ph.D., Norihiko Shiraishi, Ph.D., Noopur Raje, M.D., Zhenxin Shen, M.D., Ph.D., Tanyel Kiziltepe, Ph.D., Enrique M. Ocio, M.D., Ph.D., Klaus Podar, M.D., Ph.D., Dharminder Chauhan, Ph.D., Nikhil Munshi, M.D., Robert M. Campbell, Ph.D., Alfonso De Dios, Ph.D., Chuan Shih, Ph.D., James J. Starling, Ph.D., Kazuo Tamura, M.D., Ph.D., Kenneth C. Anderson, M.D.
Journal: Blood
Blood (2006) 108 (11): 5042.
https://doi.org/10.1182/blood.V108.11.5042.5042
Published: 2006
Journal Articles

Requirement of Caspase-8 Versus Caspase-9 during Apoptosis in Multiple Myeloma Cells Induced by Bortezomib- or a Novel Proteasome Inhibitor NPI-0052.

Dharminder Chauhan, PhD, Laurence Catley, M.D, Mugdha Velankar, M.S, Anthony Letai, M.D, Teru Hideshima, Ph.D, Klaus Podar, M.D, Hiroshi Yasui, M.D, Nicholas Mitsiades, M.D, Constantine Mitsiades, M.D, Yu-Tzu Tai, Ph.D, Noopur Raje, M.D, Nikhil Munshi, M.D, Michael A. Palladino, Ph.D, Kenneth C. Anderson, M.D
Journal: Blood
Blood (2005) 106 (11): 3378.
https://doi.org/10.1182/blood.V106.11.3378.3378
Published: 2005
Journal Articles

Hsp90 Is Critical for the Regulation of Human T Lymphocytes and NK Cell Phenotype and Function.

Jooeun Bae, PhD, Constantine Mitsiades, M.D., Rao Prabhala Prabhala, PhD, Tai Yu-Tzu, PhD, Jeff Martinson, BS, Steven Hartson, PhD, Teru Hideshima, PhD, Lawrence Catley, M.D., Xianfeng Li, BS, Ramesh Babu Batchu, PhD, Robert Bertheau, BS, Shammas Masood, PhD, Sushima Samala, M.S., Jeff Miller, PhD, Kenneth Anderson, M.D., Nikhil Munshi, M.D.
Journal: Blood
Blood (2005) 106 (11): 3464.
https://doi.org/10.1182/blood.V106.11.3464.3464
Published: 2005
Journal Articles

A Novel Orally Available Proteasome Inhibitor NPI-0052 Induces Killing in Multiple Myeloma (MM) Cells Resistant to Conventional and Bortezomib Therapies.

Dharminder Chauhan, Ph.D, Guilan Li, M.S, Klaus Podar, Ph.D, Teru Hideshima, Ph.D, Reshma Shrigarpure, Ph.D, Laurence Catley, M.D, Constantine Mitsiades, Ph.D, Nikhil Munshi, M.D, Robert Sclossman, M.D, Rena Bahjat, Ph.D, Saskia Neuteboom, M.D., Paul Richardson, M.D, Michael Palladino, Ph.D, Kenneth C. Anderson, M.D
Journal: Blood
Blood (2004) 104 (11): 2405.
https://doi.org/10.1182/blood.V104.11.2405.2405
Published: 2004
Journal Articles

Targeting Mitochondrial Factor Smac/DIABLO as Therapy for Multiple Myeloma (MM).

Dharminder Chauhan, Ph.D, Guilan Li, M.S, Teru Hideshima, Ph.D, Klaus Podar, Ph.D, Pierfrancesco Tassone, M.D., Paola E. Neri, M.D., Constantine Mitsiades, Ph.D, Nicholas Mitsiades, M.D., Noopur Raje, M.D., Shaji Kumar, M.D., Robert Schlossman, M.D., Sushil Sharma, M.D., Nikhil Munshi, M.D., Leigh Zawel, Ph.D, Kenneth C. Anderson, M.D.
Journal: Blood
Blood (2004) 104 (11): 764.
https://doi.org/10.1182/blood.V104.11.764.764
Published: 2004